Clinical Trial Update: Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating inflammation, proteolysis and IL-1 beta receptor inhibition in chronic hemodialysis patients with end-stage renal disease; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• IL-1 beta receptor inhibitor

Snippet

Sponsor: Vanderbilt University | Conditions: End Stage Renal Disease | NA | Status: COMPLETED | Results posted: 2011-11-17